Pharmaceutical Industry

Page 77 of 100

Venter
Health

AstraZeneca Is Launching a Massive Gene Hunt With This Genome Pioneer

By
April 22, 2016
Perrigo CEO Joe Papa, right, at a charity event in 2013.
Leadership

Valeant Reportedly Wants This Guy as its New CEO

By
April 22, 2016
This Is the Best Drugstore Stock to Own Now
Finance

This Is the Best Drugstore Stock to Own Now

By
April 20, 2016
The Two Mercks Are Locking Horns in a Naming Trademark Spat
Health

The Two Mercks Are Locking Horns in a Naming Trademark Spat

By
April 18, 2016
BRITAIN-PHARMA-BUSINESS-ASTRAZENECA
Finance

AstraZeneca Is Eyeing This San Francisco Drugmaker

By
April 18, 2016
Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case
Tech

Apple Again Pushes Back Against Unlocking iPhone in New York Drug Case

By
April 15, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant Talking to Investment Banks to Weigh Asset Sales

By
April 15, 2016
Inside of a Gilead Sciences Lab
Health

The FDA Wants Pharma to Ditch its Archaic Drug Making Process

By
April 14, 2016
Controversial Former Pharmaceutical CEO Martin Shkreli Testifies On Oversight In Drug Market
Health

U.S. Drug Spending Hits Record High (Again)

By
April 14, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

Valeant’s CEO Just Avoided Contempt Charges From the U.S. Senate

By
April 13, 2016
Here’s Why Shares of This Hot Biopharma Are Jumping
Finance

Here’s Why Shares of This Hot Biopharma Are Jumping

By
April 13, 2016
House Oversight Hearing On Prescription Drug Price Increases
Health

Former Shkreli-Led Drug Developer Pledges Responsible Pricing

By
April 11, 2016
Apple Starts iPhone 6 Sales In Germany
Tech

A New Smartphone App Promises Help for Schizophrenia

By
April 9, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
Finance

Intercept Pharma’s Shares Spike Before Falling On Key FDA Panel Backing

By
April 8, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By
April 7, 2016

Most Popular